V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006208 | 10004017 | 1.57 | 57 | Palliative (P) | 2018-05-19 | 2018-05-20 | PEMBROLIZUMAB | N | N | 10368627 | PEMBROLIZUMAB |
| 10006209 | 10004018 | 1.72 | 78.8 | Palliative (P) | 2017-04-08 | 2017-04-21 | PEMBROLIZUMAB | N | N | 10368627 | PEMBROLIZUMAB |
| 10006210 | 10004019 | 1.65 | 65.3 | Curative (C) | 2017-06-20 | 2018-08-14 | Docetaxel | N | N | 10368895 | DOCETAXEL |
| 10006211 | 10004021 | 1.62 | 58 | Disease modification (D) | 2017-05-04 | 2017-07-12 | Capecitabine + Oxaliplatin 14day | N | N | 10368991 | CAPECITABINE + OXALIPLATIN |
| 10006212 | 10004022 | 1.71 | 63 | Palliative (P) | 2015-10-09 | 2015-10-20 | CHOP R - 21 days | N | N | 10369159 | CHOP R |
| 10006213 | 10007127 | 1.71 | 89.1 | Curative (C) | 2015-10-13 | 2015-10-15 | Capecitabine + Oxaliplatin 21day | N | N | 10369365 | CAPECITABINE + OXALIPLATIN |
| 10006214 | 10007127 | 1.73 | 104 | Palliative (P) | 2018-07-06 | 2019-01-28 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10369365 | PACLITAXEL |
| 10006215 | 10007127 | 1.7 | 63 | Palliative (P) | 2018-08-31 | 2018-09-01 | PACLITAXEL | 2 | null | 10369365 | PACLITAXEL |
| 10006216 | 10004023 | 1.68 | 79.9 | Adjuvant (A) | 2014-08-21 | 2014-08-24 | PEMBROLIZUMAB | 2 | N | 10369490 | PEMBROLIZUMAB |
| 10006217 | 10004023 | 1.78 | 86 | Curative (C) | 2018-05-04 | 2018-05-05 | PEMBROLIZUMAB | 2 | N | 10369490 | PEMBROLIZUMAB |
| 10006218 | 10004024 | 1.66 | 86 | Curative (C) | 2019-02-17 | 2019-03-17 | Rituximab | 02 | N | 10369627 | RITUXIMAB |
| 10006219 | 10007129 | 1.7 | 58.2 | Adjuvant (A) | null | 2018-07-14 | Rituximab (INTRAVENOUS Maintenance) | N | N | 10369715 | RITUXIMAB |
| 10006220 | 10007129 | 0 | 113 | Palliative (P) | 2016-01-11 | 2016-01-11 | Oxaliplatin + Modified de Gramont | 02 | N | 10369715 | OXALIPLATIN + MDG |
| 10006221 | 10004026 | 1.71 | 89.8 | Disease modification (D) | 2018-06-24 | 2018-07-09 | CHOP R - 21 days | N | N | 10369972 | CHOP R |
| 10006222 | 10007130 | 1.55 | 95 | Palliative (P) | 2017-01-06 | 2017-04-07 | TRASTUZUMAB | N | N | 10369994 | TRASTUZUMAB |
| 10006223 | 10004028 | 1.73 | 69.2 | null | 2018-07-05 | 2018-07-28 | FLUOROURACIL + OXALIPLATIN | 02 | N | 10370049 | OXALIPLATIN + MDG |
| 10006224 | 10004029 | 1.53 | 72.7 | null | 2017-08-08 | 2017-09-05 | Docetaxel 75mg/m2 (21 day) | N | N | 10370639 | DOCETAXEL |
| 10006225 | 10007131 | 1.68 | null | Disease modification (D) | 2018-07-21 | 2018-08-08 | Rituximab | 02 | N | 10370639 | RITUXIMAB |
| 10006226 | 10004031 | 1.71 | 76 | Adjuvant (A) | 2018-02-07 | 2018-02-08 | CAPECITABINE + OXALIPLATIN | N | N | 10371240 | CAPECITABINE + OXALIPLATIN |
| 10006227 | 10007132 | 1.65 | 65.3 | null | 2015-12-19 | 2016-01-10 | IRINOTECAN + MDG | 02 | N | 10371297 | IRINOTECAN + MDG |
| 10006228 | 10004032 | 1.67 | 59 | Palliative (P) | 2016-10-29 | 2016-10-29 | Trastuzumab Subcutaneous | 02 | N | 10371297 | TRASTUZUMAB |
| 10006229 | 10004032 | 1.7 | 80 | Palliative (P) | 2018-10-21 | 2018-10-25 | Oxaliplatin + Modified de Gramont | N | N | 10371297 | OXALIPLATIN + MDG |
| 10006230 | 10004034 | 1.75 | 86 | Palliative (P) | 2016-06-19 | 2016-10-09 | Docetaxel 75mg/m2 (21 day) | N | N | 10371903 | DOCETAXEL |
| 10006231 | 10004035 | null | 87.2 | Curative (C) | 2014-09-12 | 2014-11-07 | CAPECITABINE + OXALIPLATIN | 02 | N | 10371903 | CAPECITABINE + OXALIPLATIN |
| 10006232 | 10008928 | 1.6 | 70.9 | Palliative (P) | 2018-08-26 | 2018-08-28 | TRASTUZUMAB | 02 | N | 10372236 | TRASTUZUMAB |
| 10006233 | 10004036 | 1.87 | null | Palliative (P) | 2014-12-11 | 2015-01-14 | FLUOROURACIL + OXALIPLATIN | N | N | 10372469 | OXALIPLATIN + MDG |
| 10006234 | 10004036 | 1.71 | 73 | Palliative (P) | 2018-07-16 | 2018-07-23 | Carboplatin + Etoposide iv&po | N | N | 10372469 | CARBOPLATIN + ETOPOSIDE |
| 10006235 | 10004037 | 1.82 | 74 | Palliative (P) | 2018-08-10 | 2018-08-19 | Azacitidine | 02 | N | 10372912 | AZACITIDINE |
| 10006236 | 10004039 | 1.75 | 78 | Palliative (P) | 2018-09-29 | 2018-10-21 | Bevacizumab 7.5mg/kg | N | N | 10372946 | CARBOPLATIN + PEMETREXED |
| 10006237 | 10004041 | 1.68 | 81.8 | Palliative (P) | 2017-07-21 | 2018-03-15 | CARBOPLATIN | 01 | N | 10372986 | PEMETREXED |
| 10006238 | 10004042 | 1.73 | 95 | Palliative (P) | 2015-07-26 | 2015-07-29 | Bendamustine+Rituximab(Sub Courses) | N | N | 10373083 | BENDAMUSTINE + RITUXIMAB |
| 10006239 | 10004044 | 1.71 | 78.5 | Palliative (P) | 2014-09-27 | 2015-03-19 | Capecitabine | N | N | 10373109 | CAPECITABINE |
| 10006240 | 10004044 | 1.76 | 63.4 | Palliative (P) | 2017-10-03 | 2017-10-08 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10373109 | BENDAMUSTINE + RITUXIMAB |
| 10006241 | 10004045 | 1.76 | 66.4 | Palliative (P) | 2019-04-03 | 2019-04-03 | Fluorouricil + Folonic Acid (MdG) | N | N | 10373289 | FLUOROURACIL |
| 10006242 | 10004047 | 1.65 | 67.8 | a | null | 2015-02-15 | CTD Attenuated (Thalidomide 50mg) | null | null | 10373356 | BCG |
| 10006243 | 10004047 | 1.57 | 90.6 | Palliative (P) | 2019-02-17 | 2019-02-19 | IBRUTINIB | 02 | N | 10373356 | FLUOROURACIL |
| 10006244 | 10004048 | null | 49 | Palliative (P) | 2018-04-29 | 2018-05-10 | BCG Intravesical | N | N | 10374185 | CARBOPLATIN + VINORELBINE |
| 10006245 | 10004049 | 1.56 | 82 | Disease modification (D) | 2012-08-09 | 2013-11-26 | GemCarbo Days 1+8 | null | null | 10374206 | GEMCARBO |
| 10006246 | 10004051 | 1.8 | 58 | Palliative (P) | 2016-04-02 | 2016-04-02 | BENDAMUSTINE + RITUXIMAB | 2 | Y | 10374309 | BENDAMUSTINE + RITUXIMAB |
| 10006247 | 10004052 | null | 109 | Adjuvant (A) | 2017-07-20 | 2017-07-26 | Carboplatin + Paclitaxel (3 weekly) | null | null | 10374518 | CARBOPLATIN + PACLITAXEL |
| 10006248 | 10004053 | 1.85 | 83.2 | Palliative (P) | 2016-09-14 | 2016-10-05 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10374558 | BEVACIZUMAB |
| 10006249 | 10004053 | 1.87 | 102 | Palliative (P) | 2017-04-14 | 2017-04-14 | Carboplatin + Pemetrexed | N | N | 10374558 | LENALIDOMIDE |
| 10006250 | 10004055 | 1.58 | 62 | Adjuvant (A) | null | 2018-07-17 | IBRUTINIB | 02 | N | 10374703 | CARBOPLATIN + VINORELBINE |
| 10006251 | 10004057 | null | 83 | Disease modification (D) | 2018-03-08 | 2018-03-18 | Carboplatin AUC 2 - 5 | N | N | 10375145 | GEMCARBO |
| 10006252 | 10004058 | 1.62 | 88.3 | Palliative (P) | 2014-12-14 | 2015-10-29 | CARBOPLATIN + VINORELBINE | 02 | N | 10375184 | IBRUTINIB |
| 10006253 | 10004060 | 1.7 | 83.9 | Palliative (P) | 2015-01-27 | 2015-01-27 | IBRUTINIB | 02 | N | 10375213 | GEMCARBO |
| 10006254 | 10004061 | null | 77.9 | Palliative (P) | 2015-05-10 | 2015-05-19 | Abiraterone | null | null | 10375397 | GEMCITABINE |
| 10006255 | 10004062 | 1.71 | 83.6 | Disease modification (D) | 2016-09-10 | 2016-09-19 | CYCLOPHOSPHAMIDE + THALIDOMIDE | null | null | 10375604 | CTD |
| 10006256 | 10007141 | 1.61 | 77.5 | Adjuvant (A) | 2017-08-16 | 2017-08-18 | Bevacizumab | N | N | 10375728 | BEVACIZUMAB |
| 10006257 | 10007141 | 1.86 | 63.4 | Palliative (P) | 2015-12-24 | 2016-02-15 | BCG Intravesical | N | N | 10375728 | GEMCARBO |